-
1
-
-
34548051457
-
NIH Publication No. 06-3892
-
National Diabetes Statistics, November, Available at:, Accessed July 5
-
National Diabetes Statistics. NIH Publication No. 06-3892. National Diabetes Information Clearinghouse Web site. November 2005. Available at: http://diabete.niddk.nih.gov/dm/pubs/statistics/index.htm. Accessed July 5, 2007.
-
(2005)
National Diabetes Information Clearinghouse Web site
-
-
-
2
-
-
34548024712
-
-
Jacksonville, Fla: American Association of Clinical Endocrinologists;, Available at:, Accessed June 14
-
Davidson JA, Blonde L, Jellinger PS; the ACE/AACE Diabetes Recommendations Implementation Task Force. Implementation conference for ACE outpatient diabetes mellitus consensus conference recommendations: position statement. Jacksonville, Fla: American Association of Clinical Endocrinologists; 2005. Available at: http://www.aace.com/pub/pdf/guidelines/ OutpatientImplementationPositionStatement.pdf. Accessed June 14, 2007.
-
(2005)
the ACE/AACE Diabetes Recommendations Implementation Task Force. Implementation conference for ACE outpatient diabetes mellitus consensus conference recommendations: Position statement
-
-
Davidson, J.A.1
Blonde, L.2
Jellinger, P.S.3
-
3
-
-
32144448938
-
Standards of medical care in diabetes - 2006
-
American Diabetes Association, Available at:, Accessed June 14, 2007
-
American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care. 2006;29(suppl 1):S4-S42. Available at: http://care.diabetesjournals.org/cgi/content/full/29/suppl_1/s4. Accessed June 14, 2007.
-
(2006)
Diabetes Care
, vol.29
, Issue.SUPPL. 1
-
-
-
4
-
-
0032887833
-
A desktop guide to type 2 diabetes mellitus
-
European Diabetes Policy Group
-
European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med. 1999;16:716-730.
-
(1999)
Diabet Med
, vol.1999
, Issue.16
, pp. 716-730
-
-
-
5
-
-
0242269000
-
The treat-to-target trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
for the Insulin Glargine Study Investigators, Available at:, Accessed June 14, 2007
-
Riddle MC, Rosenstock J, Gerich J, for the Insulin Glargine Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086. Available at: http://care.diabetesjournals.org/cgi/ content/full/26/11/3080. Accessed June 14, 2007.
-
(2003)
Diabetes Care
, vol.26
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
6
-
-
3042793937
-
Improved glycemic control without weight gain using triple therapy in type 2 diabetes
-
Available at:, Accessed July 5, 2007
-
Strowig SM, Aviles-Santa ML, Raskin P. Improved glycemic control without weight gain using triple therapy in type 2 diabetes. Diabetes Care. 2004;27:1577-1583. Available at: http://care.diabetesjournals.org/cgi/content/ full/27/7/1577. Accessed July 5, 2007.
-
(2004)
Diabetes Care
, vol.27
, pp. 1577-1583
-
-
Strowig, S.M.1
Aviles-Santa, M.L.2
Raskin, P.3
-
7
-
-
1042280201
-
Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: A preliminary report
-
Available at:, Accessed June 14, 2007
-
Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17-20. Available at: http://care.diabetesjournals. org/cgi/content/full/27/1/17. Accessed June 14, 2007.
-
(2004)
Diabetes Care
, vol.27
, pp. 17-20
-
-
Koro, C.E.1
Bowlin, S.J.2
Bourgeois, N.3
Fedder, D.O.4
-
8
-
-
0003613373
-
-
The National Center for Health Statistics, Hyattsville, Md: US Department of Health and Human Services;, 1997
-
The National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, Md: US Department of Health and Human Services; 1997.
-
(1988)
Third National Health and Nutrition Examination Survey
-
-
-
9
-
-
0003447646
-
-
The National Center for Health Statistics, Hyattsville, Md: US Department of Health and Human Services;
-
The National Center for Health Statistics. National Health and Nutrition Examination Survey, 1999-2000. Hyattsville, Md: US Department of Health and Human Services; 2002.
-
(2002)
National Health and Nutrition Examination Survey, 1999-2000
-
-
-
10
-
-
0347133334
-
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
-
Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
-
(2004)
JAMA
, vol.291
, pp. 335-342
-
-
Saydah, S.H.1
Fradkin, J.2
Cowie, C.C.3
-
11
-
-
8344229187
-
Waiting to inhale: Noninjectable insulin, are we there yet?
-
Hermansen K. Waiting to inhale: noninjectable insulin, are we there yet? Curr Diab Rep. 2004;4:335-341.
-
(2004)
Curr Diab Rep
, vol.4
, pp. 335-341
-
-
Hermansen, K.1
-
12
-
-
0032511583
-
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
-
-
-
-
13
-
-
0031018185
-
NIDDM patients' fears and hopes about insulin therapy: The basis of patient reluctance
-
Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care. 1997;20:292-298.
-
(1997)
Diabetes Care
, vol.20
, pp. 292-298
-
-
Hunt, L.M.1
Valenzuela, M.A.2
Pugh, J.A.3
-
14
-
-
0036736185
-
When oral agents fail: Practical barriers to starting insulin
-
Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(suppl 3):S18-S24.
-
(2002)
Int J Obes Relat Metab Disord
, vol.26
, Issue.SUPPL. 3
-
-
Korytkowski, M.1
-
15
-
-
0024455816
-
Doctors' beliefs and the management of insulin dependent diabetes: Implications for sharing care
-
Kinmonth AL, Marteau TM. Doctors' beliefs and the management of insulin dependent diabetes: implications for sharing care. Fam Pract. 1989;6:193-198.
-
(1989)
Fam Pract
, vol.6
, pp. 193-198
-
-
Kinmonth, A.L.1
Marteau, T.M.2
-
16
-
-
0035093975
-
The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes: The QuED Study Group - quality of care and outcomes in type 2 diabetes
-
for the QuED Study Group Writing Committee Coordinating Center, Available at:, Accessed June 14, 2007
-
Belfiglio M, De Berardis G, Franciosi M, Cavaliere D, Di Nardo B, Greenfield S, et al, for the QuED Study Group Writing Committee Coordinating Center. The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes: The QuED Study Group - quality of care and outcomes in type 2 diabetes. Diabetes Care. 2001;24:423-429. Available at: http://care.diabetesjournals.org/cgi/content/ full/24/3/423. Accessed June 14, 2007.
-
(2001)
Diabetes Care
, vol.24
, pp. 423-429
-
-
Belfiglio, M.1
De Berardis, G.2
Franciosi, M.3
Cavaliere, D.4
Di Nardo, B.5
Greenfield, S.6
-
17
-
-
0003191727
-
The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE system of intensive diabetes self-management - 2002 update
-
American Association of Clinical Endocrinologists
-
American Association of Clinical Endocrinologists. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management - 2002 update. Endocr Pract. 2002;8(suppl 1):40-82.
-
(2002)
Endocr Pract
, vol.8
, Issue.SUPPL. 1
, pp. 40-82
-
-
-
18
-
-
3042685448
-
Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance
-
Durbin RJ. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes Obes Metab. 2004;6:280-285.
-
(2004)
Diabetes Obes Metab
, vol.6
, pp. 280-285
-
-
Durbin, R.J.1
-
19
-
-
0036724346
-
Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
-
Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803.
-
(2002)
Diabetes
, vol.51
, pp. 2796-2803
-
-
Buchanan, T.A.1
Xiang, A.H.2
Peters, R.K.3
Kjos, S.L.4
Marroquin, A.5
Goico, J.6
-
20
-
-
34548042631
-
-
Texas Diabetes Council, Publication #45-11265. Texas Department of State Health Services. Revised April 27, Available at:, Accessed June 18
-
Texas Diabetes Council. Glycemic control algorithm for type 2 diabetes mellitus in children and adults. Publication #45-11265. Texas Department of State Health Services. Revised April 27, 2006. Available at: http://www.dshs.state.tx.us/diabetes/PDF/algorithms/PHARM2.PDF. Accessed June 18, 2007.
-
(2006)
Glycemic control algorithm for type 2 diabetes mellitus in children and adults
-
-
-
21
-
-
34548024031
-
-
Bergenstal RM, Kendall DM, Franz MJ, Rubenstein AH. Management of type 2 diabetes: a systematic approach to meeting the standards of care. II: oral agents, insulin, and management of complications. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001:821-835.
-
Bergenstal RM, Kendall DM, Franz MJ, Rubenstein AH. Management of type 2 diabetes: a systematic approach to meeting the standards of care. II: oral agents, insulin, and management of complications. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001:821-835.
-
-
-
-
23
-
-
0031878264
-
Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe
-
Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998;20:486-496.
-
(1998)
Clin Ther
, vol.20
, pp. 486-496
-
-
Graff, M.R.1
McClanahan, M.A.2
-
24
-
-
0344233275
-
A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
-
for the FlexPen Study Team
-
Korytkowski M, Bell D, Jacobsen C, Suwannasari R, for the FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003;25:2836-2848.
-
(2003)
Clin Ther
, vol.25
, pp. 2836-2848
-
-
Korytkowski, M.1
Bell, D.2
Jacobsen, C.3
Suwannasari, R.4
-
25
-
-
26944435504
-
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: A randomized, controlled trial
-
Available at:, Accessed June 18, 2007
-
Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2005;143:549-558. Available at: http://www.annals.org/ cgi/content/full/143/8/549. Accessed June 18, 2007.
-
(2005)
Ann Intern Med
, vol.143
, pp. 549-558
-
-
Rosenstock, J.1
Zinman, B.2
Murphy, L.J.3
Clement, S.C.4
Moore, P.5
Bowering, C.K.6
-
26
-
-
23044488164
-
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: A 12-week, randomized, comparative trial
-
for the Exubera Phase III Study Group, Available at:, Accessed June 14, 2007
-
DeFronzo RA, Bergenstal RM, Cefalu WT, Pullman J, Lerman S, Bode BW, et al, for the Exubera Phase III Study Group. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care. 2005;28:1922-1928. Available at: http://care.diabetesjournals.org/cgi/content/full/28/8/1922. Accessed June 14, 2007.
-
(2005)
Diabetes Care
, vol.28
, pp. 1922-1928
-
-
DeFronzo, R.A.1
Bergenstal, R.M.2
Cefalu, W.T.3
Pullman, J.4
Lerman, S.5
Bode, B.W.6
-
27
-
-
0032839780
-
Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The Barilla factory revisited
-
Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism. 1999;48:989-994.
-
(1999)
Metabolism
, vol.48
, pp. 989-994
-
-
Zavaroni, I.1
Bonini, L.2
Gasparini, P.3
Barilli, A.L.4
Zuccarelli, A.5
Dall'Aglio, E.6
-
28
-
-
0029957413
-
Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
-
Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577-1583.
-
(1996)
Diabetologia
, vol.39
, pp. 1577-1583
-
-
Hanefeld, M.1
Fischer, S.2
Julius, U.3
Schulze, J.4
Schwanebeck, U.5
Schmechel, H.6
-
29
-
-
0034641568
-
UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Available at:, Accessed July 19, 2007
-
Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al; UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412. Available at: http://www.bmj.com/cgi/content/full/321/7258/405. Accessed July 19, 2007.
-
(2000)
BMJ
, vol.321
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
-
30
-
-
0030974812
-
-
Malmberg K, for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515. Available at: http://www.bmj.com/cgi/content/full/314/7093/1512. Accessed July 19, 2007.
-
Malmberg K, for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515. Available at: http://www.bmj.com/cgi/content/full/314/7093/1512. Accessed July 19, 2007.
-
-
-
-
31
-
-
0033055724
-
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
-
Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353:617-622.
-
(1999)
Lancet
, vol.353
, pp. 617-622
-
-
Gaede, P.1
Vedel, P.2
Parving, H.H.3
Pedersen, O.4
-
32
-
-
0009766506
-
Negotiating the barrier of hypoglycemia in diabetes
-
Available at:, Accessed June 18, 2007
-
Cryer PE, Childs BP. Negotiating the barrier of hypoglycemia in diabetes. Diabetes Spectrum. 2002;15:20-27. Available at: http://spectrum. diabetesjournals.org/content/vol15/issue1/. Accessed June 18, 2007.
-
(2002)
Diabetes Spectrum
, vol.15
, pp. 20-27
-
-
Cryer, P.E.1
Childs, B.P.2
-
33
-
-
85136436269
-
-
Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization [published correction appears in JAMA. 1999;281:1989]. JAMA. 1997;278:1663-1669.
-
Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization [published correction appears in JAMA. 1999;281:1989]. JAMA. 1997;278:1663-1669.
-
-
-
-
34
-
-
0028817815
-
-
UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease [published correction appears in Diabetes. 1996;45:1655]. Diabetes. 1995;44:1249-1258.
-
UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease [published correction appears in Diabetes. 1996;45:1655]. Diabetes. 1995;44:1249-1258.
-
-
-
-
35
-
-
0034912477
-
Hypoglycemia in patients with type 2 diabetes mellitus
-
Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001;161:1653-1659.
-
(2001)
Arch Intern Med
, vol.161
, pp. 1653-1659
-
-
Miller, C.D.1
Phillips, L.S.2
Ziemer, D.C.3
Gallina, D.L.4
Cook, C.B.5
El-Kebbi, I.M.6
-
36
-
-
0034968632
-
Hypoglycemia risk reduction in type 1 diabetes
-
Cryer PE. Hypoglycemia risk reduction in type 1 diabetes. Exp Clin Endocrinol Diab. 2001;109(suppl 2):S412-S423.
-
(2001)
Exp Clin Endocrinol Diab
, vol.109
, Issue.SUPPL. 2
-
-
Cryer, P.E.1
-
37
-
-
0038336648
-
Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in type 2 diabetic patients
-
HOE 901/2004 Study Investigators Group
-
HOE 901/2004 Study Investigators Group. Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in type 2 diabetic patients. Diabet Med. 2003;20:545-551.
-
(2003)
Diabet Med
, vol.20
, pp. 545-551
-
-
-
38
-
-
12844276465
-
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
-
Available at:, Accessed June 14, 2007
-
Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care. 2005;28:254-259. Available at: http://care. diabetesjournals.org/cgi/content/full/28/2/254. Accessed June 14, 2007.
-
(2005)
Diabetes Care
, vol.28
, pp. 254-259
-
-
Janka, H.U.1
Plewe, G.2
Riddle, M.C.3
Kliebe-Frisch, C.4
Schweitzer, M.A.5
Yki-Järvinen, H.6
-
39
-
-
0038131919
-
4001 Study Group. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: A randomized, controlled trial
-
Available at:, Accessed June 18, 2007
-
Fritsche A, Schweitzer MA, Häring H-U; 4001 Study Group. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2003;138:952-959. Available at: http://www.annals.org/cgi/content/full/138/12/952. Accessed June 18, 2007.
-
(2003)
Ann Intern Med
, vol.138
, pp. 952-959
-
-
Fritsche, A.1
Schweitzer, M.A.2
Häring, H.-U.3
-
40
-
-
0033867021
-
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes
-
for the HOE 901-3002 Study Group, Available at:, Accessed June 14, 2007
-
Yki-Järvinen H, Dressler A, Ziemen M, for the HOE 901-3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23:1130-1136. Available at: http://care.diabetesjournals.org/cgi/reprint/23/8/1130. Accessed June 14, 2007.
-
(2000)
Diabetes Care
, vol.23
, pp. 1130-1136
-
-
Yki-Järvinen, H.1
Dressler, A.2
Ziemen, M.3
-
41
-
-
0037737732
-
Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: Scientific review
-
DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003;289:2254-2264.
-
(2003)
JAMA
, vol.289
, pp. 2254-2264
-
-
DeWitt, D.E.1
Hirsch, I.B.2
-
42
-
-
0642333660
-
Management of diabetes in the real world: Tight control of glucose metabolism
-
Available at:, Accessed June 18, 2007
-
Spellman CW. Management of diabetes in the real world: tight control of glucose metabolism. J Am Osteopath Assoc. 2003;103(suppl 5):S8-S13. Available at: http://www.jaoa.org/cgi/reprint/103/8_suppl_5/S8. Accessed June 18, 2007
-
(2003)
J Am Osteopath Assoc
, vol.103
, Issue.SUPPL. 5
-
-
Spellman, C.W.1
-
43
-
-
19944368427
-
LANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: Comparison of two treatment algorithms using insulin glargine
-
Available at:, Accessed June 14, 2007
-
Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R, for the AT.LANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care. 2005;28:1282-1288. Available at: http://care.diabetesjournals.org/cgi/content/full/28/6/1282. Accessed June 14, 2007.
-
(2005)
Diabetes Care
, vol.28
, pp. 1282-1288
-
-
Davies, M.1
Storms, F.2
Shutler, S.3
Bianchi-Biscay, M.4
Gomis, R.5
for the, A.T.6
-
44
-
-
34548023785
-
-
Texas Diabetes Council, Publication #45-11647. Texas Department of State Health Services. Revised October 20, Available at:, Accessed June 18
-
Texas Diabetes Council. Insulin algorithm for type 2 diabetes mellitus in children and adults. Publication #45-11647. Texas Department of State Health Services. Revised October 20, 2005. Available at: http://www.dshs.state.tx.us/ diabetes/PDF/algorithms/INST2.pdf. Accessed June 18, 2007.
-
(2005)
Insulin algorithm for type 2 diabetes mellitus in children and adults
-
-
-
46
-
-
6944244979
-
-
Raslovà K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N. Insulin detemir and insulin aspart: a promising basal bolus regimen for type 2 diabetes [published correction appears in Diabetes Res Clin Pract. 2006;72:112]. Diabetes Res Clin Pract. 2004;66:193-201.
-
Raslovà K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N. Insulin detemir and insulin aspart: a promising basal bolus regimen for type 2 diabetes [published correction appears in Diabetes Res Clin Pract. 2006;72:112]. Diabetes Res Clin Pract. 2004;66:193-201.
-
-
-
-
47
-
-
4143128768
-
Managing obesity and glycemic control in insulin-using patients: Clinical relevance and practice recommendations
-
Gottesman I. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations. Diabetes Res Clin Pract. 2004;65(suppl 1):S17-S22.
-
(2004)
Diabetes Res Clin Pract
, vol.65
, Issue.SUPPL. 1
-
-
Gottesman, I.1
-
48
-
-
0344609217
-
Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus
-
Mäkimattila S, Nikkilä K, Yki-Järvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia. 1999;42:406-412.
-
(1999)
Diabetologia
, vol.42
, pp. 406-412
-
-
Mäkimattila, S.1
Nikkilä, K.2
Yki-Järvinen, H.3
-
49
-
-
0035486744
-
Insulin therapy does not itself induce weight gain in patients with type 2 diabetes
-
Available at:, Accessed June 14, 2007
-
Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes. Diabetes Care. 2001;24:1849-1850. Available at: http://care.diabetesjournals.org/cgi/ content/full/24/10/1849. Accessed June 14, 2007.
-
(2001)
Diabetes Care
, vol.24
, pp. 1849-1850
-
-
Larger, E.1
Rufat, P.2
Dubois-Laforgue, D.3
Ledoux, S.4
-
51
-
-
0032700367
-
Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus
-
Yki-Järvinen H, Nikkilä K, Mäkimattila S. Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs. 1999;58(suppl 1):53-54,75-82.
-
(1999)
Drugs
, vol.58
, Issue.SUPPL. 1
-
-
Yki-Järvinen, H.1
Nikkilä, K.2
Mäkimattila, S.3
-
52
-
-
0345425783
-
Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
-
Available at:, Accessed June 18, 2007
-
Avilés-Santa L, Sinding J, Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:182-188. Available at: http://www.annals.org/cgi/content/full/131/3/ 182. Accessed June 18, 2007.
-
(1999)
Ann Intern Med
, vol.131
, pp. 182-188
-
-
Avilés-Santa, L.1
Sinding, J.2
Raskin, P.3
-
53
-
-
0346219295
-
Effect of thiazolidinediones on body weight in patients with diabetes mellitus
-
Fonseca V. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med. 2003;115(suppl 8A):42S-48S.
-
(2003)
Am J Med
, vol.115
, Issue.SUPPL. 8A
-
-
Fonseca, V.1
-
54
-
-
0033925345
-
Comparison of insulin regimens for patients with type 2 diabetes
-
Yki-Järvinen H. Comparison of insulin regimens for patients with type 2 diabetes. Curr Opin Endocrinol Diabetes. 2000;7:175-183.
-
(2000)
Curr Opin Endocrinol Diabetes
, vol.7
, pp. 175-183
-
-
Yki-Järvinen, H.1
-
55
-
-
26944477362
-
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: A randomized trial
-
for the GWAA Study Group, Available at:, Accessed June 18, 2007
-
Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG, for the GWAA Study Group. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2005;143:559-569. Available at: http://www.annals.org/cgi/content/full/ 143/8/559. Accessed June 18, 2007.
-
(2005)
Ann Intern Med
, vol.143
, pp. 559-569
-
-
Heine, R.J.1
Van Gaal, L.F.2
Johns, D.3
Mihm, M.J.4
Widel, M.H.5
Brodows, R.G.6
-
56
-
-
12744274870
-
Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
-
Haak T, Tiengo A, Draeger E, Suntum W, Waldhäusl W. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab. 2005;7:56-64.
-
(2005)
Diabetes Obes Metab
, vol.7
, pp. 56-64
-
-
Haak, T.1
Tiengo, A.2
Draeger, E.3
Suntum, W.4
Waldhäusl, W.5
-
57
-
-
0002295222
-
Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes [abstract 0347]
-
Bergenstal R, Johnson M, Whipple D, et al. Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes [abstract 0347]. Diabetes. 1998;47(suppl 1):A89.
-
(1998)
Diabetes
, vol.47
, Issue.SUPPL. 1
-
-
Bergenstal, R.1
Johnson, M.2
Whipple, D.3
-
58
-
-
0028966408
-
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients
-
Chow CC, Tsang LW, Sorensen JP, Cockram CS. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes Care. 1995;18:307-314.
-
(1995)
Diabetes Care
, vol.18
, pp. 307-314
-
-
Chow, C.C.1
Tsang, L.W.2
Sorensen, J.P.3
Cockram, C.S.4
-
59
-
-
0029067658
-
Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM
-
Cusi K, Cunningham GR, Comstock JP. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care. 1995;18:843-851.
-
(1995)
Diabetes Care
, vol.18
, pp. 843-851
-
-
Cusi, K.1
Cunningham, G.R.2
Comstock, J.P.3
-
60
-
-
0029123497
-
Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure
-
Landstedt-Hallin L, Adamson U, Arner P, Bolinder J, Lins PE. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure. Diabetes Care. 1995;18:1183-1186.
-
(1995)
Diabetes Care
, vol.18
, pp. 1183-1186
-
-
Landstedt-Hallin, L.1
Adamson, U.2
Arner, P.3
Bolinder, J.4
Lins, P.E.5
-
61
-
-
0034827469
-
Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin
-
Available at:, Accessed June 14, 2007
-
Rosenstock J, Schwartz SL, Clark Jr CM, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care. 2001;24:631-636. Available at: http://care.diabetesjournals.org/cgi/content/full/24/4/631. Accessed June 14, 2007.
-
(2001)
Diabetes Care
, vol.24
, pp. 631-636
-
-
Rosenstock, J.1
Schwartz, S.L.2
Clark Jr, C.M.3
Park, G.D.4
Donley, D.W.5
Edwards, M.B.6
-
62
-
-
0343724362
-
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: A randomized, controlled trial
-
Available at:, Accessed June 18, 2007
-
Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1999;130:389-396. Available at: http://www.annals.org/cgi/content/full/130/5/ 389. Accessed June 18, 2007.
-
(1999)
Ann Intern Med
, vol.130
, pp. 389-396
-
-
Yki-Järvinen, H.1
Ryysy, L.2
Nikkilä, K.3
Tulokas, T.4
Vanamo, R.5
Heikkilä, M.6
-
63
-
-
18144401971
-
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
-
DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care. 2005;28:1092-1100.
-
(2005)
Diabetes Care
, vol.28
, pp. 1092-1100
-
-
DeFronzo, R.A.1
Ratner, R.E.2
Han, J.3
Kim, D.D.4
Fineman, M.S.5
Baron, A.D.6
|